ARISE - Aggressive Reduction of Inflammation Stops Events

Clinical trial NCT00066898 · UNKNOWN

Trial details

NCT number: NCT00066898
Sponsor: AtheroGenics
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerosis Coronary Artery Disease Myocardial Infarction Unstable Angina

Start date: 2003-06-01
Enrollment: 6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.